Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...

Selena Gomez is looking to part with her Los Angeles home, which was originally custom-built for singer Tom Petty in the 1980s. Gomez, 33, listed the Encino home for sale earlier this month for nearly ...

Recursion Pharmaceuticals uses its AI-driven platform to manage a deep pipeline of drug candidates through strategic partnerships with industry giants. Schrödinger leverages physics-based software to ...

The Reserve Bank of India is considering the introduction of polymer banknotes into circulation, reviving a proposal first floated over a decade ago, as the cost of printing paper currency surges and ...

Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026. Analysts expect potential upside from rare diseases.